Holen Sie sich die Stockscreener-App
9.72
0.31%
-0.03
Handel nachbörslich:
9.73
0.010
+0.10%
Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten
What MACD and RSI say about Amneal Pharmaceuticals Inc.Oil Prices & Accurate Technical Buy Alerts - newser.com
Assessing Amneal Pharmaceuticals (AMRX) Valuation After BLA Submission and Eased Regulatory Risks - Sahm
What to expect from Amneal Pharmaceuticals Inc. in the next 30 daysJuly 2025 Closing Moves & AI Forecasted Stock Moves - newser.com
Will Amneal Pharmaceuticals Inc. stock benefit from automationVolume Spike & Safe Capital Growth Tips - newser.com
Amneal seeks FDA nod for generic targeting Xolair marketed by Roche and Novartis - MSN
Amneal Pharmaceuticals Hits New 52-Week High of $10.67 - Markets Mojo
FDA grants tentative approval for Amneal generic of Bausch Health's Xiafan - MSN
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
How Amneal’s (AMRX) Biosimilar XOLAIR Application Could Shape Its Specialty Pharma Ambitions - Sahm
Will Amneal Pharmaceuticals Inc. see short term momentumTrade Analysis Report & Daily Volume Surge Signals - newser.com
Why Amneal Pharmaceuticals Inc. stock is considered a top pick2025 Market Outlook & Smart Swing Trading Alerts - newser.com
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs - Benzinga
Will Amneal Pharmaceuticals Inc. price bounce be sustainable2025 Earnings Surprises & Reliable Entry Point Trade Alerts - newser.com
When is the best time to exit Amneal Pharmaceuticals Inc.July 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
The Bull Case For Amneal Pharmaceuticals (AMRX) Could Change Following Biosimilar XOLAIR FDA Submission – Learn Why - Yahoo Finance
Technical analysis overview for Amneal Pharmaceuticals Inc. stockEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
A Look at Amneal Pharmaceuticals’s Valuation After XOLAIR Biosimilar Submissions and Recent Analyst Upgrades - Yahoo Finance
Amneal Pharmaceuticals (NASDAQ:AMRX) Receives Hold (C) Rating from Weiss Ratings - MarketBeat
Amneal Pharmaceuticals, Inc. (AMRX) Files BLA for XOLAIR® Biosimilar, Targets Multi-Billion-Dollar Market - MSN
Amneal Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now? - sharewise.com
Does Amneal Pharmaceuticals Still Offer Value After 36% Surge and New Product Approvals in 2025? - Sahm
Amneal Pharmaceuticals (NASDAQ:AMRX) Increases 6.9% This Week, Taking Three-year Gains to 420% - 富途牛牛
Measuring Amneal Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Selloffs & Low Volatility Stock Recommendations - newser.com
Take the Zacks Approach to Beat the Markets: Amneal Pharmaceuticals, Leidos & Vishay Precision in Focus - Nasdaq
Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab) - Business Wire
Applying Wyckoff theory to Amneal Pharmaceuticals Inc. stockJuly 2025 Retail & Daily Oversold Bounce Ideas - newser.com
Reversal indicators forming on Amneal Pharmaceuticals Inc. stockEarnings Trend Report & Expert Approved Momentum Ideas - newser.com
Is it time to cut losses on Amneal Pharmaceuticals Inc.Quarterly Portfolio Review & Proven Capital Preservation Methods - newser.com
Using Python tools to backtest Amneal Pharmaceuticals Inc. strategies2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com
Sentiment analysis tools applied to Amneal Pharmaceuticals Inc.Portfolio Risk Summary & High Win Rate Trade Tips - newser.com
How to read the order book for Amneal Pharmaceuticals Inc.Trade Signal Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Will breakout in Amneal Pharmaceuticals Inc. lead to full recoveryGap Down & Comprehensive Market Scan Insights - newser.com
Amneal Pharmaceuticals Hits New 52-Week High of $10.43 - Markets Mojo
Is Amneal Pharmaceuticals Inc. stock cheap compared to fundamentalsEarnings Growth Report & Safe Entry Zone Identification - newser.com
Chart based exit strategy for Amneal Pharmaceuticals Inc.Market Volume Summary & Smart Investment Allocation Insights - newser.com
What analysts say about Amneal Pharmaceuticals Inc stockGap Up/Gap Down Analysis & Free Take Advantage Of Momentum - earlytimes.in
Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year? - sharewise.com
3 Lesser-Known Healthcare Names With Major Upside in Store - sharewise.com
3 Lesser-Known Healthcare Names With Major Upside in Store - Investing.com
Amneal Pharmaceuticals stock hits 52-week high at $10.36 By Investing.com - Investing.com Canada
Amneal Pharmaceuticals stock hits 52-week high at $10.36 - Investing.com
0.90%
2.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):